Biblio

Author Title Type [ Year(Asc)]
Filters: Author is Bajel, Ashish  [Clear All Filters]
2023
Lew TE, Cliff ERScheffer, Dickinson M, Tam CS, Seymour JF, Blombery P, Bajel A, Ritchie D, Khot A. Allogeneic stem cell transplantation achieves long-term remissions in mantle cell lymphoma, including in -mutated disease. Leuk Lymphoma. 2023:1-9.
Moore J, Hamad N, Gottlieb DJ, Bajel A, Ritchie DS, Yeung DT, Greenwood M, Purtill D, Tran S, Solterbeck A, et al. Early cessation of calcineurin inhibitors is feasible post haploidentical blood stem cell transplant-the ANZHIT-1 study. Blood Adv. 2023.
Tew M, Douglas AP, Szer J, Bajel A, Harrison SJ, Tio SYen, Worth LJ, Hicks RJ, Ritchie D, Slavin MA, et al. Evaluating the cost-effectiveness of [F]FDG-PET/CT for investigation of persistent or recurrent neutropenic fever in high-risk haematology patients. Cancer Imaging. 2023;23(1):119.
McErlean G, Bajel A, Bhattacharyya A, Brown N, Lourenco RDe Abreu, Greenwood M, Kerridge I, Kim N, Kliman D, Maneze D, et al. If we do not count it, it does not count: ethnicity in allogeneic haemopoietic stem cell transplant in Australia. Intern Med J. 2023.
2022
Douglas A, Thursky K, Spelman T, Szer J, Bajel A, Harrison S, Tio SYen, Bupha-Intr O, Tew M, Worth L, et al. [F]FDG-PET-CT compared with CT for persistent or recurrent neutropenic fever in high-risk patients (PIPPIN): a multicentre, open-label, phase 3, randomised, controlled trial. Lancet Haematol. 2022.
2020
Zhou Z, Nath R, Cerny J, Wang H-L, Zhang M-J, Abdel-Azim H, Agrawal V, Ahmed G, A Al-Homsi S, Aljurf M, et al. Reduced intensity conditioning for acute myeloid leukemia using melphalan- vs busulfan-based regimens: a CIBMTR report. Blood Adv. 2020;4(13):3180-3190.
2019
Xie O, Khan S, Globan M, Lea K, Bajel A, Slavin M. Mycobacterium abscessus bloodstream infection: unexpected catheter tunnel infection localised by PET/CT. Transpl Infect Dis. 2019:e13147.
2018
Radivoyevitch T, Dean RM, Shaw BE, Brazauskas R, Tecca HR, Molenaar RJ, Battiwalla M, Savani BN, Flowers MED, Cooke KR, et al. Risk of acute myeloid leukemia and myelodysplastic syndrome after autotransplants for lymphomas and plasma cell myeloma. Leuk Res. 2018.
2014
Lim ABM, Roberts AW, Mason K, Bajel A, Szer J, Ritchie DS. Validating the Allogeneic Stem Cell Transplantation Disease Risk Index: Sample Size, Follow-up, and Local Data Are Important. Transplantation. 2014.